Type I photosensitizers (PSs) are a promising approach for photodynamic therapy (PDT) since they can generate radicals that are tolerant to hypoxia. Thus, the development of highly efficient type I… Click to show full abstract
Type I photosensitizers (PSs) are a promising approach for photodynamic therapy (PDT) since they can generate radicals that are tolerant to hypoxia. Thus, the development of highly efficient type I PSs is essential. Self-assembly is a promising strategy for developing novel PSs with desirable properties. In this study, we developed a simple and effective approach to create heavy-atom-free PSs for PDT by self-assembling long-tailed BODIPYs. The resulting aggregates BY-I16 and BY-I18 can efficiently convert their excited energy to the triplet state, producing reactive oxygen species (ROS) that are essential for PDT. Furthermore, we can regulate the aggregation and PDT performance by adjusting the length of the tailed alkyl chains. As proof of concept, we demonstrated the efficacy of these heavy-atom-free PSs both in vitro and in vivo under both normoxic and hypoxic conditions. This article is protected by copyright. All rights reserved.
               
Click one of the above tabs to view related content.